{
  "id": "5c6545bae842deac6700001d",
  "type": "factoid",
  "question": "Which molecular does daratumumab target?",
  "ideal_answer": "Daratumumab is an anti-CD38 antibody.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29500635"
  ],
  "snippets": [
    {
      "text": "The addition of daratumumab (anti-CD38 antibody) augmented NK-cell cytotoxicity against target cells expressing high CD38, but not against CD38 low or negative target cells also in the presence of TME.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29500635",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "CD38"
}